Fischer Medical Ventures Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Fischer Medical Ventures Ltd · Outcome · 15 Nov 2026, 5:01 am
Fischer Medical Ventures Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 10,744 (+24.5% YoY | +31.1% QoQ) ■ EBITDA: 894 (-44.8% YoY | -20.5% QoQ) ■ EBITDA Margin (%): 8.3 (-1046 bps YoY | -541 bps QoQ) ■ PAT: 80.5 (-94.2% YoY | -78.8% QoQ) ■ EPS (INR): 0.01 (-99.5% YoY | -80.0% QoQ)
Original exchange filing (PDF)
More announcements from Fischer Medical Ventures Ltd
- Financial results for the quarter and half year ended 30th Sept 2026 · 15 Nov 2026
- Outcome of Board Meeting held on 14th Nov 2026 for approval of Q2 financials · 15 Nov 2026
- The Monitoring Agency Report for the quarter ended 30 September 2026 is enclosed. · 14 Nov 2026
- Fischer Medical Ventures Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve the unaudited standalone .... · 14 Nov 2026
- Appointment of Mr Chan Sing En as an Independent Director of FMV Global Innovations Pte.Ltd, Singapore, a Material Wholly Owned Subsidiary Company · 27 Oct 2026
- Postal Ballot Notice & Scrutinizer · 14 Oct 2026
